Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_319eed6d6813db49e8057bdaa5e60233 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-2821 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6896 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-92 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-535 |
filingDate |
2007-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b0a4c015349d93d562c81c66ac7ac7bd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_91340286c8d969ab7586cff9bf0f7719 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_04d45ffacbb47967667e0bdc2aef9d67 |
publicationDate |
2010-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2010035286-A1 |
titleOfInvention |
In vitro method for the diagnosis and early diagnosis of neurodegenerative disorders |
abstract |
In vitro method for the detection and early detection of, for the determination of the degree of severity of, and for the assessment of the course of and prognosis of neurodegenerative disorders, in which an immunodiagnostic determination method is used to determine the apolipoprotein C-1 (Apo C-1) immunoreactivity in a serum or plasma sample from a patient suffering from subjective or objectively verifiable cognitive disorders. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111650372-A |
priorityDate |
2006-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |